Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2020

May 4, 2020

35081_dirs_2020-05-04_a3ee2eb0-89ed-41d2-95ea-86ce5315dca1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-04-30

Reporting Person: MOYES JAY M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-04-30 Common Stock A 20250 Acquired 24211 Direct
2020-04-30 Common Stock A 3750 Acquired 27961 Direct

Footnotes

F1: The award relates to vested restricted stock units ("RSUs") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan.